1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro- structure
|
Common Name | 1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro- | ||
---|---|---|---|---|
CAS Number | 54824-17-8 | Molecular Weight | 313.30800 | |
Density | 1.384g/cm3 | Boiling Point | 496.8ºC at 760 mmHg | |
Molecular Formula | C16H15N3O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 254.3ºC |
Use of 1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro-Mitonafide (NSC 300288) is a cytostatic agent. Mitonafide binds to double-stranded DNA through intercalation, and inhibits DNA and RNA synthesis. Mitonafide is an antitumor agent that can be used in the research of cancers, such as non-small cell lung cancer (NSCLC), leukemia[1][2][3]. |
Name | 2-[2-(dimethylamino)ethyl]-5-nitrobenzo[de]isoquinoline-1,3-dione |
---|---|
Synonym | More Synonyms |
Description | Mitonafide (NSC 300288) is a cytostatic agent. Mitonafide binds to double-stranded DNA through intercalation, and inhibits DNA and RNA synthesis. Mitonafide is an antitumor agent that can be used in the research of cancers, such as non-small cell lung cancer (NSCLC), leukemia[1][2][3]. |
---|---|
Related Catalog | |
Target |
DNA and RNA synthesis[1] |
In Vitro | Mitonafide inhibits DNA and RNA synthesis and induces single-strand breaks in the DNA of chinese hamster ovary cells[1]. The incubation of Mitonafide with rat liver microsomes and NADPH under anaerobic conditions results in the formation of a metabolite identified as 5-aminomitonafide[2]. Mitonafide (25, 50 μM, 1 h) induces single-stand breaks in the DNA of L1210 cells[2]. Mitonafide (10-100 μM) exhibits cytotoxic effect in the HOP-62 lung cell line[4]. Cell Viability Assay[6] Cell Line: SK-OV-3, HepG2, A-549, T-24, SMMC-7721, HL-7702 Concentration: 0-100 μM respectively. Incubation Time: 48 h Result: Inhibited cell viability with IC50 values of 6.26, 10.88, 7.94, 5.01, 6.94, 8.51 μM. |
In Vivo | Mitonafide (0.5 and 1 mg/kg, i.p., 1-7 days) shows antitumoral potency in S-180 bearing mice[4]. Mitonafide (5 mg/kg, i.p., twice a day) shows anticancer activity in HepG2 xenograft model[6]. Mitonafide (single i.p. injection, S-180 bearing mice) shows the LD50 value of 10.0 mg/kg[5]. Animal Model: S-180 bearing mice[4] Dosage: 0.5 mg/kg and 1 mg/kg Administration: Intraperitoneal injection (i.p.) for 1-7 days Result: Increased in median survival times. Animal Model: HepG2 xenograft model [6] Dosage: 5 mg/kg Administration: Intraperitoneal injection (i.p.), twice a day. Result: Exhibited a relative tumor increment rates (T/C) value of 28.8%. |
References |
Density | 1.384g/cm3 |
---|---|
Boiling Point | 496.8ºC at 760 mmHg |
Molecular Formula | C16H15N3O4 |
Molecular Weight | 313.30800 |
Flash Point | 254.3ºC |
Exact Mass | 313.10600 |
PSA | 88.13000 |
LogP | 1.94570 |
Index of Refraction | 1.667 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
HS Code | 2933990090 |
---|
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
2-(2-(dimethylamino)ethyl)-3-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione |
Mitonafidum [INN-Latin] |
Mitonafida [INN-Spanish] |
M 4212 (Pharmaceutical) |
2-(2-(dimethylamino) ethyl)-5-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione |
N-(2-(Dimethylamino)ethyl)-3-nitronaphthalimide |
M-4212 |
2-(2-dimethylaminoethyl)-5-nitrobenzo[de]isoquinoline-1,3-dione |
Mitonafide |